News
Aridis Pharmaceuticals Inc (NASDAQ: ARDS) shares are gaining after announcing positive European Medicines Agency feedback on its proposed single confirmatory Phase 3 study of investigational ...
Intravenous Propofol bests Inhaled Sevoflurane for improving ventilation and survival in ARDS: Study
Researchers have found in a new clinical trial comparing sedation methods for patients with moderate to severe ARDS that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback